Prevalence, awareness, treatment and control of dyslipidaemia and their determinants: results from a population-based survey of 60 283 residents in eastern China

Y Chen, J Du, N Zhou, Y Song, W Wang, X Hong - BMJ open, 2023 - bmjopen.bmj.com
Objectives To investigate the prevalence, awareness, treatment and control of dyslipidaemia
and its associated factors in eastern China. Design Cross-sectional study. Setting Data were …

The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

FL Zhang, YQ Xing, YH Wu, HY Liu, Y Luo… - Lipids in health and …, 2017 - Springer
Background Dyslipidemia is an important independent modifiable risk factor for
cardiovascular disease. The aim of this study was to explore the current prevalence …

Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China

L Cai, L Zhang, A Liu, S Li, P Wang - Journal of atherosclerosis and …, 2012 - jstage.jst.go.jp
Aim: The present study aimed to determine the up-to-date prevalence, awareness,
treatment, and control of dyslipidemia, and their distribution and related influencing factors in …

The prevalence, awareness, treatment and control of dyslipidemia among adults in China

L Pan, Z Yang, Y Wu, RX Yin, Y Liao, J Wang, B Gao… - Atherosclerosis, 2016 - Elsevier
Objectives To analyze the prevalence, awareness, treatment, control and epidemiological
characteristics of dyslipidemia in Chinese adults. Methods In this cross-sectional study, we …

Prevalence and associated factors of dyslipidemia in the adult Chinese population

S Wang, L Xu, JB Jonas, QS You, YX Wang, H Yang - PloS one, 2011 - journals.plos.org
To determine the prevalence, associated factors, awareness and control of dyslipidemia in
Chinese living in Greater Beijing, we measured the serum cholesterol concentration in 3251 …

[HTML][HTML] Prevalence, awareness, treatment, and control of dyslipidemia in Chinese adults: a systematic review and meta-analysis

Q Xia, Y Chen, Z Yu, Z Huang, Y Yang… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Background Researchers have conducted a considerable number of epidemiological
studies on dyslipidemia in China over recent years. Nevertheless, a representative study to …

Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study

H He, Y Yu, Y Li, C Kou, B Li, Y Tao, Q Zhen… - Lipids in health and …, 2014 - Springer
Abstract Background In China, even though the prevalence of dyslipidemia among adults
increased yearly and dyslipidemia being an important risk factor for cardiovascular diseases …

Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey

J Luo, YT Ma, Z Yu, YN Yang, X Xie, X Ma, F Liu… - Lipids in health and …, 2014 - Springer
Aim The aim of this study was to estimate the prevalence, awareness, treatment, and control
of dyslipidemia in Xinjiang, China. Method Stratified sampling method was used to select a …

Epidemiology of dyslipidemia in Chinese adults: meta-analysis of prevalence, awareness, treatment, and control

Y Huang, L Gao, X Xie, SC Tan - Population health metrics, 2014 - Springer
Background Numerous epidemiology studies on dyslipidemia have been conducted in
China. However, a nationally representative estimate for dyslipidemia prevalence is lacking …

Prevalence of dyslipidemia and availability of lipid-lowering medications among primary health care settings in China

Y Lu, H Zhang, J Lu, Q Ding, X Li, X Wang… - JAMA network …, 2021 - jamanetwork.com
Importance Dyslipidemia, the prevalence of which historically has been low in China, is
emerging as the second leading yet often unaddressed factor associated with the risk of …